Trials / Completed
CompletedNCT01071681
Survey to Assess Why People Are Not Responding to Treatment in Hypertension
Observational Survey Assessing the Factors of Treatment Intensification in Uncontrolled Hypertensive Patients Under a Combination Therapy, Either Fixed or Not, of a Renin-Angiotensin System Blocker (RASB) and Hydrochlorothiazide (HCTZ), According to Their Level of Cardiovascular Risk.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,589 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will describe the factors influencing the physician in face of elevated blood pressure in already treated patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Telmisartan (Kinzal/Pritor, BAY68-9291) | Patients under daily life treatment receiving Pritor according to local drug information. |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2010-02-19
- Last updated
- 2011-11-02
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01071681. Inclusion in this directory is not an endorsement.